Navigation Links
Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008
Date:4/9/2008

FLORHAM PARK, N.J., April 9 /PRNewswire/ -- Defined Health has announced the final agenda and speaker list for its 8th annual Therapeutic Insight conference. Therapeutic Insight 2008 ("TI2008") will take place on April 28 - 30, 2008, at The Westin New York at Times Square. The following industry decision-makers and key opinion leaders will discuss relevant pharma/biotech issues and current trends in oncology, cardiovascular disease, neuropsychiatric disorders, antimicrobials, therapeutic vaccines and orphan diseases:

* Professor Ruth Arnon, The Paul Ehrlich Professor of Immunology,

Weizmann Institute of Science

* Charles Baum, MD, PhD, Vice President, Global R&D, Oncology, Pfizer

* Karen Bernstein, PhD, Chairman and Editor-in-Chief, BioCentury

* Thomas P. Blackburn, PhD, DSc, TPBioVentures LLC

* Jeffrey M. Bockman, PhD, Vice President, Defined Health

* Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and

Medical Officer, ARCA Discovery

* Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc.

* Shannon Brownlee, Schwartz Senior Fellow, New American Foundation

* Michael D. Clayman, MD, CEO, Flexion Therapeutics

* Earl M. (Duke) Collier, Jr., JD, Executive Vice President, Genzyme

Corporation

* Albert R. Collinson, PhD, Chief Business Officer, Rib-X Pharmaceuticals

* Lode Debrabandere, PhD, Vice President & General Manager Inflammatory

Diseases, Osiris

* Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, Dendreon

Corporation

* Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma

* Milton H. Grannatt, PhD, Vice President and Head, Negotiations, New

Growth Opportunities, Global Business Development & Licensing, Novartis

Pharmaceuticals Corporation

* Russell Hagan, PhD, Senior Vice President, Head of Research &

Development, BTG International

* Roger J. Hajjar, MD, Director, Cardiovascular Research Center, Mt.

Sinai School of Medicine, Arthur & Janet C. Ross Professor of Medicine,

Co-founder Celladon Corporation, Co-founder Nanocor Inc.

* Steven J. Heller, Global Marketing Leader, Oncology New Product

Development and Early Commercial Input, Johnson & Johnson Worldwide

Strategic Marketing

* Professor Jutta Heim, PhD, Chief Scientific Officer, Basilea

Pharmaceutica

* Claudia Hirawat, SVP Corporate Development, PTC Therapeutics

* Ginger S. Johnson, PhD, Vice President, Defined Health

* Matthew W. Kalnik, PhD, VP, Business Development & Project Management,

Nabi Biopharmaceuticals

* Jeremy Levin, PhD, Senior Vice President, External Science, Technology

and Licensing, Bristol-Myers Squibb

* Christopher Lipinski, PhD, Scientific Advisor, Melior Discovery

* Joseph S. McCracken, DVM, Vice President, Business & Commercial

Development, Genentech

* David P. Meeker, MD, President, LSD Therapeutics, Genzyme

* Eszter Nagy, MD, PhD, Vice President, Pre-clinical R&D, Intercell

* Steve J. Offord, PhD, Vice President CNS New Products Marketing, Market

Access and Business Development, sanofi-aventis

* Carlos Plata-Salaman, DSc, MD, Head, Global External Research &

Development, Eli Lilly & Co.

* Edward C. Saltzman, President, Defined Health

* Deborah Schrag, MD, Associate Professor of Medicine, Dana-Farber Cancer

Institute

* Mark J. Simon, President, Williver Group LLC

* Greg Wiederrecht, PhD, Vice President & Head, External Scientific

Affairs, Merck & Co.

* Daphne Zohar, Founder & Managing Partner, PureTech Ventures

The final agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences is available on the conference website, http://www.therapeuticinsight.com.

Shannon Brownlee, Schwartz Senior Fellow at the New America Foundation, will present a keynote address at TI2008 entitled, "Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer." Her book of the same title was named the best economics book of 2007 by the New York Times. Ms. Brownlee's speaking fee will be donated to charity.

The 2+ day conference will include two networking events, with additional opportunities for interaction throughout the event. The conference will begin on Tuesday morning, April 29, with a plenary presentation by Ed Saltzman, President of Defined Health, entitled: "Surviving, Sustaining and Succeeding in the Pursuit of Innovation."

Therapeutic Insight 2008 is presented by Defined Health and Communitech Market Intelligence, with a sponsorship from JNK Securities. To register, or for more information, please visit http://www.therapeuticinsight.com, or contact Communitech: (914) 245-7764, http://www.cmius.com, or Defined Health: (973) 292-5001, http://www.definedhealth.com.

Contact:

Ginny E. Llobell

Vice President

Defined Health

973-292-5001 X 235


'/>"/>
SOURCE Defined Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sensitivity of brain center for sound space defined
2. Pathway to cell death redefined in landmark study
3. Pathway to cell death redefined in landmark study
4. John Hancock Launches Defined Benefit Program
5. New upper limit defined for normal ALT in adolescent males
6. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology: